Therapeutic Innovation Research Center, Federal University of Pernambuco, Av. Moraes Rego, 1235, Recife, 50670-901, Brazil.
Department of Virology and Experimental Therapy, Aggeu Magalhães Institute, Oswaldo Cruz Foundation / FIOCRUZ, Av. Moraes Rego, 1235, Recife, 50670-901, Brazil.
Curr Top Med Chem. 2024;24(25):2224-2237. doi: 10.2174/0115680266315388240801053401.
In this study, we have synthesized 19 Thiazolidine (TZD) derivatives to investigate their potential anti-ZIKV effects.
Nineteen thiazolidine derivatives were synthesized and evaluated for their cytotoxicity and antiviral activity against the ZIKA virus.
Among them, six demonstrated remarkable selectivity against the ZIKV virus, exhibiting IC50 values of <5μM, and the other compounds did not demonstrate selectivity for the virus. Interestingly, several derivatives effectively suppressed the replication of ZIKV RNA copies, with derivatives significantly reducing ZIKV mRNA levels at 24 hours post-infection (hpi). Notably, two derivatives (ZKC-4 and -9) stood out by demonstrating a protective effect against ZIKV cell entry. Informed by computational analysis of binding affinity and intermolecular interactions within the NS5 domain's N-7 and O'2 positions, ZKC-4 and FT-39 displayed the highest predicted affinities. Intriguingly, ZKC-4 and ZKC-9 derivatives exhibited the most favorable predicted binding affinities for the ZIKV-E binding site.
The significance of TZDs as potent antiviral agents is underscored by these findings, suggesting that exploring TZD derivatives holds promise for advancing antiviral therapeutic strategies.
在这项研究中,我们合成了 19 种噻唑烷(TZD)衍生物,以研究它们潜在的抗 ZIKV 作用。
合成了 19 种噻唑烷衍生物,并评估了它们对 ZIKA 病毒的细胞毒性和抗病毒活性。
其中,有 6 种对 ZIKV 病毒表现出显著的选择性,IC50 值<5μM,其他化合物对病毒没有选择性。有趣的是,几种衍生物能有效抑制 ZIKV RNA 拷贝的复制,其中两种衍生物(ZKC-4 和 -9)在感染后 24 小时(hpi)时显著降低 ZIKV mRNA 水平。值得注意的是,两种衍生物(ZKC-4 和 FT-39)在阻止 ZIKV 细胞进入方面表现出保护作用。基于对 NS5 结构域 N-7 和 O'2 位置的结合亲和力和分子间相互作用的计算分析,ZKC-4 和 FT-39 显示出最高的预测亲和力。有趣的是,ZKC-4 和 ZKC-9 衍生物对 ZIKV-E 结合位点表现出最有利的预测结合亲和力。
这些发现强调了 TZDs 作为有效抗病毒药物的重要性,表明探索 TZD 衍生物有希望推进抗病毒治疗策略。